Assyro AI

Orange Book product · Brand (NDA)

OBREDON

GUAIFENESIN; HYDROCODONE BITARTRATE

Brand (NDA)NDA 205474DISCN SOVEREIGN PHARMS

At a glance

Nov 14, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 14, 2014

    11 yr 9 mo ago

  2. Today

  3. Patent 10105324 expires

    Listed drug substance patent expiration.

    Nov 13, 2035

    in 9 yr 6 mo

  4. Patent 9549907 expires

    Listed drug substance patent expiration.

    Nov 13, 2035

    in 9 yr 6 mo

  5. Patent 9808431 expires

    Listed drug substance patent expiration.

    Nov 13, 2035

    in 9 yr 6 mo

Pharmaceutical detail

Active ingredient

GUAIFENESIN; HYDROCODONE BITARTRATE

Strength

200MG/5ML;2.5MG/5ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 205474

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10105324Nov 13, 2035in 9 yr 6 mo
SubstanceProductU-2023
9549907Nov 13, 2035in 9 yr 6 mo
SubstanceProductU-2023
9808431Nov 13, 2035in 9 yr 6 mo
SubstanceProductU-2023
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.